Cardiogoniometry Zur Früherkennung Akuter Myokardischämien Bei ACS-Symptomatik
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chest Pain
- Sponsor
- Stiftung Institut fuer Herzinfarktforschung
- Enrollment
- 249
- Primary Endpoint
- Difference between cardiogoniometry finding and leading diagnoses of chest pain unit, coronary angiography, and at discharge in assessing the origin of chest pain
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
Aims of the study:
Patients in a Chest Pain Unit (CPU) are examined to clarify if the cause of pain is cardiac or not. To identify patients with ST-elevation and other electrocardiogram (ECG) modifications a normal 12-lead ECG is used. The diagnosis non-st-elevation myocardial infarction is determined with the help of the ischemic marker Troponin. However, Troponin levels are elevated earliest 3 to 4 hours after the ischemic event, so that a negative Troponin result at the time of hospital admission is insufficient. Thus the guidelines of the German Society of Cardiology demand a second measurement after 6 to 12 hours. In rare cases false positive Troponin levels have been reported (e.g. in patients with renal insufficiency).
The aim of this study is to determine if in the early phase of diagnostic assessment cardiogoniometry can improve differentiation between patients with cardiac (ischemic) emergency and patients with non-cardiac (non-ischemic) cause of pain. Furthermore it will be evaluated if cardiogoniometry is capable to diagnose patients with non-ST-elevation myocardial infarction (NSTEMI) to the same extent as Troponin. This could avoid time loss until a possibly necessary catheter intervention ("fast track").
To clarify these questions the result of the cardiogoniometry will be compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard). Therefore the performance of cardiac catheterization within 72 hours after start of symptoms is a mandatory inclusion criterion.
Detailed Description
The cardiogoniometry vectorcardiography is a procedure that allows a stress-free and non-invasive diagnosis of myocardial ischemia: five thoracic electrodes as well as the heart flow in orthogonal summation vectors are recorded by a computer-assisted method in three dimensions.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \> 18 years
- •thoracic pain, or pain radiating to neck or arm, or acute dyspnoea
- •coronary angiography within 72 hours after start of symptoms
Exclusion Criteria
- •ST elevation myocardial infarction
- •hemodynamically unstable patients, provided that the application of CGM may lead to an unacceptable delay in diagnosis and therapy
- •lack of blood samples for troponin determination at admission
- •patients with cardiac pacemaker
- •cardiogenic shock
- •tachycardia (HR \> 100)
- •\> 50% extra systoles
- •branch block
- •atrial fibrillation
- •no informed consent
Outcomes
Primary Outcomes
Difference between cardiogoniometry finding and leading diagnoses of chest pain unit, coronary angiography, and at discharge in assessing the origin of chest pain
Time Frame: 72 hours
Aim is to examine if cardiogoniometry can provide additional information for the decision to perform a diagnostic coronary angiography and if so, which additional value it has. To assess the value of cardiogoniometry its results are compared with the leading diagnosis of the Chest Pain Unit, the diagnosis at hospital discharge as well as with the angiographic findings (as a gold standard).